Amanote Research
Register
Sign In
Figure 6: VEGF Inhibitor Avastin Prevented the Role of RSG in BM-EPCs Induced by High Glucose.
doi 10.7717/peerj.7815/fig-6
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
PeerJ
Related search
Supplemental Information 6: VEGF Inhibitor Avastin Prevented the Role of RSG in BM-EPCs Induced by High Glucose
Glucose-Induced Microvascular Functional Changes in Nondiabetic Rats Are Stereospecific and Are Prevented by an Aldose Reductase Inhibitor.
Journal of Clinical Investigation
Medicine
High-Altitude Cognitive Impairment Is Prevented by Enriched Environment Including Exercise via VEGF Signaling
Frontiers in Cellular Neuroscience
Molecular Neuroscience
Cellular
Role of mTOR Signaling in the Regulation of High Glucose‑induced Podocyte Injury
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Corneal Neovascularization and the Utility of Topical VEGF Inhibition: Ranibizumab (Lucentis) vs Bevacizumab (Avastin)
Ocular Surface
Ophthalmology
Blockage of VEGF-Induced Angiogenesis by Preventing VEGF Secretion
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
High Glucose and Glucose Deprivation Modulate Müller Cell Viability and VEGF Secretion
International Journal of Ophthalmology & Eye Science
Aldose Reductase Inhibitor Improves Insulin-Mediated Glucose Uptake and Prevents Migration of Human Coronary Artery Smooth Muscle Cells Induced by High Glucose
Hypertension
Internal Medicine
Degradation of BM SDF-1 by MMP-9: The Role in G-CSF-Induced Hematopoietic Stem/Progenitor Cell Mobilization
Bone Marrow Transplantation
Transplantation
Hematology
